KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ionis Pharmaceuticals (IONS) EPS (Basic): 2009-2024

Historic EPS (Basic) for Ionis Pharmaceuticals (IONS) over the last 16 years, with Dec 2024 value amounting to -$3.04.

  • Ionis Pharmaceuticals' EPS (Basic) rose 15.79% to -$0.80 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.61, marking a year-over-year increase of 34.02%. This contributed to the annual value of -$3.04 for FY2024, which is 18.75% down from last year.
  • Ionis Pharmaceuticals' EPS (Basic) amounted to -$3.04 in FY2024, which was down 18.75% from -$2.56 recorded in FY2023.
  • Ionis Pharmaceuticals' 5-year EPS (Basic) high stood at -$0.20 for FY2021, and its period low was -$3.18 during FY2020.
  • Its 3-year average for EPS (Basic) is -$2.50, with a median of -$2.56 in 2023.
  • Its EPS (Basic) has fluctuated over the past 5 years, first surged by 93.71% in 2021, then crashed by 850.00% in 2022.
  • Ionis Pharmaceuticals' EPS (Basic) (Yearly) stood at -$3.18 in 2020, then spiked by 93.71% to -$0.20 in 2021, then slumped by 850.00% to -$1.90 in 2022, then plummeted by 34.74% to -$2.56 in 2023, then decreased by 18.75% to -$3.04 in 2024.